PSI CRO was honored to be invited to Navigating the Ever-Changing Clinical Trials Landscape in Southeast Asia, an insightful event hosted by Biotech Connection Singapore, Intrinseque Health, and Geneo at Singapore Science Park. Bringing together over 100 professionals from the biotechnology and pharmaceutical sectors, the event featured keynote presentations, a dynamic panel discussion, and invaluable networking opportunities.
PSI’s Tracy Thia, Director of Therapeutic Strategy, joined the expert panel to share insights on:
- Patient-Centric Clinical Trials – Designing real-world, operationally feasible studies to minimize patient burden.
- Operationalizing Complex Trials – Careful oversight of each step in the IP management process, especially in radiopharmaceutical and T-cell therapies, to ensure that the IP reaches the specific patient within a narrow time window
- Managing Timeline Delays & Budget Overruns – Leveraging PSI’s AI-enabled clinical trial platform to improve planning accuracy, INTELIA™, including VISIONAL for study modeling and CLARITY for trial budgeting
As clinical trials grow increasingly complex, innovation and collaboration remain critical in overcoming challenges and accelerating drug development. Events like this bring together industry leaders to exchange ideas, drive progress, and ultimately, improve patient outcomes.
Additional news coverage can be found here.
